Clinical trial
Study Protocol Used in Maternal Inheritance of a Pathogenic MT-ND1 Mutation Causes Mitochondrial Dysfunction and Spermatogenic Failure in Men
NCT07691827 is registered in ClinicalTrials.gov with The Third Affiliated Hospital of Guangzhou Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Study Protocol Used in Maternal Inheritance of a Pathogenic MT-ND1 Mutation Causes Mitochondrial Dysfunction and Spermatogenic Failure in Men
- Lead sponsor
- The Third Affiliated Hospital of Guangzhou Medical University
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- April 1, 2021
- Completion date
- June 1, 2027
- Enrollment
- 1,200 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
azoospermia, nonobstructive, cryptozoospermia